References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30
- Early Breast Cancer Trialists’ Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet 2015;386:1341-52
- American Cancer Society. Breast Cancer: facts & figures 2013–2014. Atlanta, GA: American Cancer Society, 2013 Available at: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. Accessed October 28, 2015
- Weide R, Feiten S, Friesenhahn V, et al. Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors. Springerplus 2014;3:535
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology (NCCN Guidelines). Breast Cancer. Version 1.2016. Fort Washington, PA: National Comprehensive Cancer Network, 2015. Available at: https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed December 18, 2015
- Andre F, Neven P, Marinsek N, et al. Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer. Curr Med Res Opin 2014;30:1007-16
- Howlader N, Altekruse SF, Li CI, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 2014;106:5
- Hess GP, Wang PF, Quach D, et al. Systemic therapy for metastatic colorectal cancer: patterns of chemotherapy and biologic therapy use in US medical oncology practice. J Oncol Pract 2010;6:301-7
- Chastek B, Kulakodlu M, Valluri S, Seal B. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization. Postgrad Med 2013;125:73-82
- United States Department of Labor, Bureau of Labor Statistics. Consumer Price Index Overview. Washington, DC: United States Department of Labor, Bureau of Labor Statistics, 2015. Available at: http://www.bls.gov/cpi/cpiovrvw.htm#item1. Accessed January 13, 2016
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29
- Kiely BE, Soon YY, Tattersall MHN, et al. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol 2011;29:456-63
- Carlson RW, Burstein HJ, Ward JH. Sequencing of hormonal therapy in metastatic breast cancer. Medscape, New York, NY, 2009. Available at: http://www.medscape.org/viewarticle/714021_transcript. Accessed February 15, 2016